Correlation Between Unicycive Therapeutics and Surrozen

Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Surrozen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Surrozen into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Unicycive Therapeutics and Surrozen, you can compare the effects of market volatilities on Unicycive Therapeutics and Surrozen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Surrozen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Surrozen.

Diversification Opportunities for Unicycive Therapeutics and Surrozen

0.54

Correlation Coefficient

Unicycive Therapeutics  Surrozen

Very weak diversification

The 3 months correlation between Unicycive and Surrozen is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Surrozen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Surrozen and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Surrozen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Surrozen has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Surrozen go up and down completely randomly.

Pair Corralation between Unicycive Therapeutics and Surrozen

Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 1.3 times less return on investment than Surrozen. But when comparing it to its historical volatility, Unicycive Therapeutics is 1.26 times less risky than Surrozen. It trades about 0.03 of its potential returns per unit of risk. Surrozen is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  1,223  in Surrozen on December 22, 2024 and sell it today you would earn a total of  22.00  from holding Surrozen or generate 1.8% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Unicycive Therapeutics  vs.  Surrozen

Unicycive Therapeutics

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Unicycive Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Unicycive Therapeutics may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Surrozen

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Surrozen are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain basic indicators, Surrozen displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Unicycive Therapeutics and Surrozen

The main advantage of trading using opposite Unicycive Therapeutics and Surrozen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Surrozen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Surrozen will offset losses from the drop in Surrozen's long position.

The idea behind Unicycive Therapeutics and Surrozen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.